Merck Launches First All-in-One Genetic Stability Assay to Accelerate Biosafety Testing
- Written by The Post
- Proprietary Aptegra™ platform reduces five assays to one
- Results in 66% faster testing time and significantly lower cost for clients compared to traditional methods
- Only platform that meets all regulatory requirements to establish CHO genetic stability with a single test
SINGAPORE - Media OutReach Newswire - 17 April 2024 - Merck, a leading science and technology company, has launched the first all-in-one, validated genetic stability assay of its kind.
